Stéphane Ascarateil

641 total citations
9 papers, 405 citations indexed

About

Stéphane Ascarateil is a scholar working on Immunology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Stéphane Ascarateil has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Stéphane Ascarateil's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Advanced Drug Delivery Systems (2 papers). Stéphane Ascarateil is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Advanced Drug Delivery Systems (2 papers). Stéphane Ascarateil collaborates with scholars based in Netherlands, Lithuania and United Kingdom. Stéphane Ascarateil's co-authors include Laurent Dupuis, J. Aucouturier, S. Deville, Marius Strioga, Virgil E.J.C. Schijns and A. Laval and has published in prestigious journals such as Annals of the New York Academy of Sciences, Vaccine and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Stéphane Ascarateil

9 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Ascarateil Netherlands	6	222	148	85	73	56	9	405
Diana Haddad Sweden	11	264 1.2×	136 0.9×	67 0.8×	83 1.1×	166 3.0×	17	510
Victória Alves Santos Lunardelli Brazil	7	158 0.7×	105 0.7×	73 0.9×	94 1.3×	52 0.9×	10	321
Christoph M. Janitzek Denmark	9	167 0.8×	310 2.1×	84 1.0×	85 1.2×	73 1.3×	14	540
Luciana D’Apice Italy	14	233 1.0×	235 1.6×	70 0.8×	137 1.9×	31 0.6×	29	582
K H Wiesmüller Germany	12	195 0.9×	193 1.3×	134 1.6×	65 0.9×	23 0.4×	16	449
Marie Rojas France	8	251 1.1×	158 1.1×	97 1.1×	86 1.2×	27 0.5×	8	432
Beverly K. Dyas United States	12	177 0.8×	188 1.3×	55 0.6×	144 2.0×	41 0.7×	18	482
Laural B. Harper United States	5	247 1.1×	330 2.2×	86 1.0×	187 2.6×	17 0.3×	5	585
Thomas G. Griffiths United States	7	253 1.1×	346 2.3×	92 1.1×	189 2.6×	17 0.3×	8	632
Karin Lövgren‐Bengtsson Sweden	12	171 0.8×	96 0.6×	94 1.1×	146 2.0×	33 0.6×	18	396

Countries citing papers authored by Stéphane Ascarateil

Since Specialization

Citations

This map shows the geographic impact of Stéphane Ascarateil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Ascarateil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Ascarateil more than expected).

Fields of papers citing papers by Stéphane Ascarateil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Ascarateil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Ascarateil. The network helps show where Stéphane Ascarateil may publish in the future.

Co-authorship network of co-authors of Stéphane Ascarateil

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Ascarateil. A scholar is included among the top collaborators of Stéphane Ascarateil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Ascarateil. Stéphane Ascarateil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ascarateil, Stéphane, et al.. (2015). Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines. Journal for ImmunoTherapy of Cancer. 3(S2). 28 indexed citations

2.

Ascarateil, Stéphane, et al.. (2015). Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations

3.

Schijns, Virgil E.J.C., Marius Strioga, & Stéphane Ascarateil. (2014). Oil‐Based Emulsion Vaccine Adjuvants. Current Protocols in Immunology. 106(1). 2.18.1–2.18.7. 10 indexed citations

4.

Deville, S., et al.. (2009). Control of pig vaccine safety trought adjuvant design and vaccination protocol: example of a divalent Pasteurella multocida toxin and Bordetella bronchiseptica vaccine. Revue Méd Vét. 160(11). 514–519. 3 indexed citations

5.

Dupuis, Laurent, et al.. (2009). Veterinary vaccine adjuvants. Veterinary Immunology and Immunopathology. 128(1-3). 248–249. 1 indexed citations

6.

Dupuis, Laurent, et al.. (2006). SEPPIC Vaccine Adjuvants for Poultry. Annals of the New York Academy of Sciences. 1081(1). 202–205. 27 indexed citations

7.

Ascarateil, Stéphane & Laurent Dupuis. (2005). Surfactants in vaccine adjuvants: description and perspectives. Vaccine. 24. S83–S85. 15 indexed citations

8.

Aucouturier, J., Stéphane Ascarateil, & Laurent Dupuis. (2005). The use of oil adjuvants in therapeutic vaccines. Vaccine. 24. S44–S45. 88 indexed citations

9.

Aucouturier, J., et al.. (2002). Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Review of Vaccines. 1(1). 111–118. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact